HK1125828A1 - Long term treatment of hiv- infection with tcm278 - Google Patents

Long term treatment of hiv- infection with tcm278

Info

Publication number
HK1125828A1
HK1125828A1 HK09103670.2A HK09103670A HK1125828A1 HK 1125828 A1 HK1125828 A1 HK 1125828A1 HK 09103670 A HK09103670 A HK 09103670A HK 1125828 A1 HK1125828 A1 HK 1125828A1
Authority
HK
Hong Kong
Prior art keywords
tcm278
hiv
infection
long term
term treatment
Prior art date
Application number
HK09103670.2A
Other languages
English (en)
Inventor
Lieven Elvire Colette Baert
Guenter Kraus
Klooster Gerben Albert Eleutherius Van T
Original Assignee
Janssen R & D Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36446113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1125828(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen R & D Ireland filed Critical Janssen R & D Ireland
Publication of HK1125828A1 publication Critical patent/HK1125828A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK09103670.2A 2006-01-20 2009-04-21 Long term treatment of hiv- infection with tcm278 HK1125828A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100677 2006-01-20
PCT/EP2007/050516 WO2007082922A2 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278

Publications (1)

Publication Number Publication Date
HK1125828A1 true HK1125828A1 (en) 2009-08-21

Family

ID=36446113

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09103670.2A HK1125828A1 (en) 2006-01-20 2009-04-21 Long term treatment of hiv- infection with tcm278

Country Status (28)

Country Link
US (2) US10953009B2 (ja)
EP (1) EP1981506B3 (ja)
JP (2) JP5754005B2 (ja)
KR (2) KR101562943B1 (ja)
CN (2) CN103877091A (ja)
AP (1) AP2936A (ja)
AR (1) AR059097A1 (ja)
AU (1) AU2007206901B2 (ja)
BR (1) BRPI0707179A2 (ja)
CA (1) CA2636436C (ja)
CY (1) CY1114089T1 (ja)
DK (1) DK1981506T6 (ja)
EA (1) EA014914B1 (ja)
ES (1) ES2414982T7 (ja)
HK (1) HK1125828A1 (ja)
HR (1) HRP20130544T4 (ja)
IL (1) IL192132A (ja)
ME (1) ME01617B (ja)
MY (1) MY150717A (ja)
NZ (1) NZ569347A (ja)
PL (1) PL1981506T6 (ja)
PT (1) PT1981506E (ja)
RS (1) RS52821B2 (ja)
SG (1) SG170073A1 (ja)
SI (1) SI1981506T1 (ja)
TW (1) TWI458483B (ja)
UA (1) UA96436C2 (ja)
WO (1) WO2007082922A2 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
AU2016219555B2 (en) * 2006-06-23 2017-08-10 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
UA97641C2 (en) * 2006-06-23 2012-03-12 Тиботек Фармасьютикелз Лтд. Aqueous suspensions of tmc278
AU2014200819B2 (en) * 2006-06-23 2016-05-26 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
SG172398A1 (en) * 2008-12-24 2011-07-28 Tibotec Pharm Ltd Implantable devices for treating hiv
CN102573815B (zh) * 2009-09-22 2015-09-30 泰博特克药品公司 Hiv感染的治疗和预防
NZ600156A (en) * 2009-12-21 2015-01-30 Janssen R & D Ireland Degradable removable implant for the sustained release of an active compound
ES2688925T3 (es) 2010-01-27 2018-11-07 Viiv Healthcare Company Tratamiento antiviral
TWI577377B (zh) 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
US9266824B2 (en) 2014-01-13 2016-02-23 Warsaw Orthopedic, Inc. Methods and compositions for making an amino acid triisocyanate
US10406098B2 (en) * 2015-11-16 2019-09-10 Evonik Roehm Gmbh Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
US20190163877A1 (en) * 2017-11-27 2019-05-30 International Business Machines Corporation Decision support for effective long-term drug therapy
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
US6568805B1 (en) * 2001-11-26 2003-05-27 Dan L. Dietz Trust Magnetic buckle for eyeglasses
EP1525216A4 (en) * 2002-01-24 2009-07-08 Sangstat Medical Corp COMBINATION THERAPY FOR THE TREATMENT OF HIV INFECTION
PL1632232T6 (pl) * 2004-09-02 2022-06-27 Janssen Pharmaceutica Nv Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu
SI1632232T1 (sl) * 2004-09-02 2011-09-30 Janssen Pharmaceutica Nv Sol 4((4((4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)amino) benzonitrila
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防

Also Published As

Publication number Publication date
EP1981506B3 (en) 2021-06-09
AP2936A (en) 2014-07-31
EA014914B1 (ru) 2011-02-28
WO2007082922A8 (en) 2008-01-03
RS52821B (en) 2013-10-31
RS52821B2 (sr) 2021-07-30
US10953009B2 (en) 2021-03-23
NZ569347A (en) 2011-07-29
AP2008004535A0 (en) 2008-08-31
EA200870183A1 (ru) 2009-12-30
JP5754005B2 (ja) 2015-07-22
EP1981506A2 (en) 2008-10-22
EP1981506B1 (en) 2013-03-27
CA2636436A1 (en) 2007-07-26
DK1981506T6 (da) 2021-06-14
BRPI0707179A2 (pt) 2011-04-26
SG170073A1 (en) 2011-04-29
MY150717A (en) 2014-02-28
CA2636436C (en) 2014-04-01
IL192132A (en) 2014-05-28
HRP20130544T4 (hr) 2021-08-20
JP2009526758A (ja) 2009-07-23
WO2007082922A2 (en) 2007-07-26
KR101562943B1 (ko) 2015-10-23
AR059097A1 (es) 2008-03-12
PT1981506E (pt) 2013-06-25
ES2414982T7 (es) 2021-11-05
KR20080085194A (ko) 2008-09-23
ME01617B (me) 2014-09-20
ES2414982T3 (es) 2013-07-23
KR101501475B1 (ko) 2015-03-19
US20110275654A1 (en) 2011-11-10
TW200806295A (en) 2008-02-01
DK1981506T3 (da) 2013-06-24
JP2013100338A (ja) 2013-05-23
TWI458483B (zh) 2014-11-01
HRP20130544T1 (en) 2013-07-31
WO2007082922A3 (en) 2007-09-20
JP5836983B2 (ja) 2015-12-24
PL1981506T3 (pl) 2013-08-30
CY1114089T1 (el) 2016-07-27
SI1981506T1 (sl) 2013-08-30
CN103877091A (zh) 2014-06-25
CN101370504A (zh) 2009-02-18
AU2007206901B2 (en) 2013-01-31
KR20140141699A (ko) 2014-12-10
AU2007206901A1 (en) 2007-07-26
US20210177843A1 (en) 2021-06-17
IL192132A0 (en) 2009-08-03
PL1981506T6 (pl) 2021-07-12
UA96436C2 (ru) 2011-11-10

Similar Documents

Publication Publication Date Title
HRP20130544T1 (en) Long term treatment of hiv- infection with tcm278
HUS1800011I1 (hu) Kombinációs terápia szubsztituált oxazolidinonokkal
GB0610867D0 (en) Treatment of pain
IL193748A0 (en) Treatment of pain
GB0624874D0 (en) Treatment
GB0600692D0 (en) Well treatment
GB0702931D0 (en) Skin application
GB0909297D0 (en) Composition for the treatment of skin conditions
ZA200806505B (en) Treatment of HIV
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
GB0610868D0 (en) Treatment of pain
GB0607952D0 (en) Novel treatment
GB0723100D0 (en) Treatment of HFnEF
GB0604460D0 (en) Treatment
GB0616450D0 (en) Treatment of pain
GB0623740D0 (en) Treatment of disease
GB0714500D0 (en) composition and treatment
GB0602857D0 (en) The treatment of sialorrhoea
GB0602858D0 (en) The treatment of sialorrhoea
GB0602855D0 (en) The Treatment Of Sialorrhoea
GB0625602D0 (en) Treatment of sialorrhoea
GB0601091D0 (en) The Treatment Of Ocular Conditions
GB0610431D0 (en) Treatment
GB0605781D0 (en) Treatment
GB0609789D0 (en) Treatment of inflammation